Abstract
Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients with Hereditary Transthyretin-Mediated Amyloidosis (766)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have